Human Larynx and Pharynx Tissue MicroArray (Cancer)

Images

 
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 01. Larynx, Pyriform Sinus squamous Cell
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 2. Larynx subglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 03. Larynx, supraglottic squamous cell
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 04. Esophagus squamous carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 05. Larynx, transglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 06. Larynx pyriform, sinus squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 07. Larynx, supraglettic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 08. Larynx, glottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 09. Larynx, supraglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 10. Larnyx glottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 11. Larynx, supraglottic squamous cell
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 12. Larynx, Pyriform sinus squamous cell
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 13. Larynx, supraglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 14. Larynx, Transglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 15. Larynx, Supraglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 16. Soft tissue, neck, squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 17. Larynx, supraglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 18. Soft tissue, neck squamous cell
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 19. Larynx, supraglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 20. Nasal cavity and undifferentiated carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 21. Larynx, Transglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 22. Lymph node metastic undifferentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 23. Nasopharynx, Undifferentiated carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 24. Neck, Undifferentiated carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 25. Larynx, Transglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 26. Neck squamous cell carcinoma, Moderately differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 27. Nasal cavity, Squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 28. Larynx, subglottic squamous cell carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 29. Larynx, transglottic squamous cell carcinoma, well differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 30. Oropharynx undifferentiated carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 31. Hypopharynx squamous cell carcinoma, poorly differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 32. Larynx, pyriform sinus squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 33. Soft tissue, neck squamous cell carcinoma (from larynx)
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 34. Larynx, Supraglottic squamous cell
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 35. Larynx subglottic squamos cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 36. Larynx supraglottic squamos cell
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 37. Larynx, supraglottic squamous cell carcinoma, well differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 38. Submandibular gland undifferentiated carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 39. Tonsil squamous cell carcinoma, poorly differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 40. Nose squamous cell carcinoma, poorly differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 41. Larynx, glottic squamous cell carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 42. Skin, neck undifferentiated carcinoma (from nasopharynx)
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 43. Larynx, supraglottic squamous cell carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 44. Larynx, subglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 45. Larynx, transglottic squamous cell carcinoma, well differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 46. Larynx, glottic squamous cell carcinoma, poorly differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 47. Larynx, subglottic squamous cell carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 48. Larynx, glottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 49. Larynx, supraglottic squamous cell carcinoma, poorly differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 50. Larynx, supraglottic squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 51. Larynx, pyriform sinus squamous cell carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 52. Maxilla undifferentiated carcinoma
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 53.Larynx, glottic squamous cell carcinoma, well differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 54.Larynx, supraglottic squamous cell carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 55.Epiglottis squamous cell carcinoma, basaloid type
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 56.Epiglottis squamous cell carcinoma, moderately differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 57.Lymph node, neck metastatic undifferentiated carcinoma, (primary site unknown)
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 59.Larynx, supraglottic squamous cell carcinoma, poorly differentiated
Hematoxylin & Eosin Stain: Human Larynx and Pharynx Tissue MicroArray (Cancer) [NBP2-30270] - 58. Larynx, glottic squamous cell carcinoma, poorly differentiated

Product Details

Summary
Reactivity HuSpecies Glossary
Applications IHC-P

Order Details

Human Larynx and Pharynx Tissue MicroArray (Cancer) Summary

Description
Microarray Panel:
Larynx and pharynx cancer
No. of samples 59
No. of patients 59
Core diameter 2.0 mm
Format:Formalin Fixed
Section thickness 4 micrometer
Core#
No.
Age Sex Organ Diagnosis pTNM Stage Tissue
type
Image
1 43 M Larynx, pyriform sinus squamous cell carcinoma, moderately differentiated T4aN3M0 IVB 6
2 55 M Larynx, subglottic squamous cell carcinoma, moderately differentiated T4aN0M0 IVA 6
3 72 M Larynx, supraglottic squamous cell carcinoma, moderately differentiated T3N0M0 III 6
4 63 M Esophagus squamous cell carcinoma, basaloid type T3N0M0 III 6
5 67 M Larynx, transglottic squamous cell carcinoma, well differentiated T4aN2bM0 IVA 6
6 63 M Larynx, pyriform sinus squamous cell carcinoma, moderately differentiated T3N2cM0 IVA 6
7 60 M Larynx, supraglottic squamous cell carcinoma, moderately differentiated T4aN2cM0 IVA 6
8 61 M Larynx, glottic squamous cell carcinoma, moderately differentiated T4aN0M0 IVA 6
9 66 M Larynx, supraglottic squamous cell carcinoma, moderately differentiated T4aN2cM0 IVA 6
10 56 M Larynx, glottic squamous cell carcinoma, well differentiated T1aN0M0 I 6
11 62 M Larynx, supraglottic squamous cell carcinoma, moderately differentiated T3N2cM0 IVA 6
12 56 M Larynx, pyriform sinus squamous cell carcinoma, moderately differentiated T4aN2bM0 IVA 6
13 54 M Larynx, supraglottic squamous cell carcinoma, well differentiated T3N0M0 III 6
14 48 M Larynx, transglottic squamous cell carcinoma, well differentiated T3N0M0 III 6
15 61 M Larynx, supraglottic squamous cell carcinoma, well differentiated T3N0M0 III 6
16 66 M Soft tissue, neck squamous cell carcinoma, well differentiated (from hypopharynx) T4aN0M0 IVA 6
17 51 M Larynx, supraglottic squamous cell carcinoma, moderately differentiated T4aN2cM0 IVA 6
18 46 M Soft tissue, neck squamous cell carcinoma (from hypopharynx) T3N2aM0 IVA 6
19 52 M Larynx, supraglottic squamous cell carcinoma, moderately differentiated T3N0M0 III 6
20 52 F Nasal cavity undifferentiated carcinoma T4NxM0 IVA 6
21 64 M Larynx, transglottic squamous cell carcinoma, basaloid type T3N2bM0 IVA 6
22 28 F Lymph node metastatic undifferentiated carcinoma (from nasopharynx) T1N1M0 II 6
23 63 M Nasopharynx undifferentiated carcinoma TxN2M1 IVC 6
24 77 M Neck undifferentiated carcinoma TxN1M0 . 6
25 51 M Larynx, transglottic squamous cell carcinoma, well differentiated T4aN2bM0 IVA 6
26 67 F Neck squamous cell carcinoma, moderately differentiated (from hypopharynx) TxN0M0 . 6
27 59 M Nasal cavity squamous cell carcinoma, poorly differentiated T4N0M0 IVA 6
28 55 M Larynx, subglottic squamous cell carcinoma, moderately differentiated T3N0M0 III 6
29 60 M Larynx, transglottic squamous cell carcinoma, well differentiated T4aN0M0 IVA 6
30 70 M Oropharynx undifferentiated carcinoma T1N2aM0 IVA 6
31 55 M Hypopharynx squamous cell carcinoma, poorly differentiated T4aN1M0 IVA 6
32 62 M Larynx, pyriform sinus squamous cell carcinoma T3N0M0 III 6
33 48 M Soft tissue, neck squamous cell carcinoma (from larynx) T2N1M0 III 6
34 66 M Larynx, supraglottic squamous cell carcinoma, moderately differentiated T4aN2bM0 IVA 6
35 58 M Larynx, subglottic squamous cell carcinoma, well differentiated T4aN0M0 IVA 6
36 76 M Larynx, supraglottic squamous cell carcinoma, moderately differentiated T3N1M0 III 6
37 61 M Larynx, supraglottic squamous cell carcinoma, well differentiated T4aN2bM0 IVA 6
38 66 M Submandibular gland undifferentiated carcinoma T3N2M0 III 6
39 54 M Tonsil squamous cell carcinoma, poorly differentiated T2N2bM0 IVA 6
40 61 M Nose squamous cell carcinoma, poorly differentiated T3N0M0 III 6
41 65 M Larynx, glottic squamous cell carcinoma, moderately differentiated T3NxM1 IVC 6
42 54 M Skin, neck undifferentiated carcinoma (from nasopharynx) T4N2M0 IVA 6
43 82 F Larynx, supraglottic squamous cell carcinoma, moderately differentiated T3N1M0 III 6
44 56 M Larynx, subglottic squamous cell carcinoma T4aN2bM0 IVA 6
45 75 M Larynx, transglottic squamous cell carcinoma, well differentiated T4aN0M0 IVA 6
46 69 M Larynx, glottic squamous cell carcinoma, poorly differentiated T4aN2cM0 IVA 6
47 43 M Larynx, subglottic squamous cell carcinoma, moderately differentiated T3N0M0 III 6
48 60 M Larynx, glottic squamous cell carcinoma T4aN0M0 IVA 6
49 66 M Larynx, supraglottic squamous cell carcinoma, poorly differentiated T2N0M0 II 6
50 52 M Larynx, supraglottic squamous cell carcinoma T3N1M0 II 6
51 58 M Larynx, pyriform sinus squamous cell carcinoma T4aN2cM0 IVA 6
52 47 F Maxilla undifferentiated carcinoma T1N0M0 I 6
53 65 M Larynx, glottic squamous cell carcinoma, well differentiated T4N2bM0 IVA 6
54 78 M Larynx, supraglottic squamous cell carcinoma, moderately differentiated T3N1M0 III 6
55 69 M Epiglottis squamous cell carcinoma, basaloid type T2N0M0 II 6
56 60 M Epiglottis squamous cell carcinoma, moderately differentiated T2N2cM0 IVA 6
57 46 F Lymph node, neck metastatic undifferentiated carcinoma, (primary site unknown) . . 6
58 70 M Larynx, glottic squamous cell carcinoma, poorly differentiated T4aN2cM0 IVA 6
59 79 M Larynx, supraglottic squamous cell carcinoma, poorly differentiated T3N2cM0 IVA 6
60 . . Carbon . . . .


Applications/Dilutions

Publications
Read Publication using
NBP2-30270 in the following applications:

Reactivity Notes

Human

Packaging, Storage & Formulations

Storage
Store at 4C. Do not freeze.

Details for Larynx and Pharynx

Type
Tissue
Tissue Condition
Cancer

Alternate Names for Human Larynx and Pharynx Tissue MicroArray (Cancer)

  • Larynx & Pharynx

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Tissue Micro Arrays are guaranteed for 1 year from date of receipt.

Publications for Larynx and Pharynx Tissue Micro Array (NBP2-30270)(1)

We have publications tested in 1 confirmed species: Human.

We have publications tested in 1 application: IHC-P.


Filter By Application
IHC-P
(1)
All Applications
Filter By Species
Human
(1)
All Species

Reviews for Larynx and Pharynx Tissue Micro Array (NBP2-30270) (0)

There are no reviews for Larynx and Pharynx Tissue Micro Array (NBP2-30270). By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
  • Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
  • Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
  • 1st to review with an image -- $50/€35/£30/$50 CAD/¥300 Yuan/¥5000 Yen

Product General Protocols

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs for Larynx and Pharynx Tissue Micro Array (NBP2-30270). (Showing 1 - 1 of 1 FAQ).

  1. Do we have access to patient data (demographic, clinical, follow-up)? Please let me know.
    • For some of our Tissue Arrays, supplementary data like survival data is available upon purchase for the tissues. For NBP2-30270, all the information we have for the tissue donors is found on our website under the Description section. You can view this data by clicking the link that says: "See more information".

Additional Larynx and Pharynx Products

Larynx and Pharynx NBP2-30270

Blogs on Larynx and Pharynx

There are no specific blogs for Larynx and Pharynx, but you can read our latest blog posts.

Contact Information

Product PDFs

Review this Product

Be the first to review our Human Larynx and Pharynx Tissue MicroArray (Cancer) and receive a gift card or discount.